Concepedia

Publication | Open Access

Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors

76

Citations

52

References

2019

Year

References

YearCitations

Page 1